Buprenorphine Transdermal Patch and Metaxalone: Interaction Details
- Metaxalone
- Skelaxin
- Buprenorphine Transdermal Patch
- ButransBelbucaSublocade +2 more
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS
Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
- Dr. Brian Staiger, PharmD, BCPS, is a clinical pharmacist and pharmacotherapy specialist.
- AI-assisted, written
- AI is used only to summarize verified clinical information, never the open internet.
- Editorial policy
- How we build our interaction pages →
- Our AI policy →
A close look at the Buprenorphine Transdermal Patch and Metaxalone interaction:
Buprenorphine Transdermal Patch
- Butrans
- Belbuca
- Sublocade
- Buprenex
- Brixadi
What Happens When You Take Buprenorphine Transdermal Patch With Metaxalone
What can happen when they are taken together (rated Major)
Increased risk of , an increased risk of and an increased risk of
Interaction Deep Dive
A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →
Cases of serotonin syndrome have been reported when metaxalone, given at doses within its usual , was used together with agents.1 In addition, combining muscle relaxants with can produce CNS depression, which raises the risk of respiratory depression, profound , coma, and death.
Concurrent prescribing should be limited to patients who have no adequate alternative treatment options. When combined use cannot be avoided, the lowest effective dose and the shortest necessary duration should be used. Patients should be monitored for sedation, respiratory depression, urinary retention, and severe constipation, and prescribing naloxone for emergency treatment of opioid overdose should be strongly considered.23
The Buprenorphine Transdermal Patch and Metaxalone Interaction, Explained
Taking metaxalone (a muscle relaxant) with a buprenorphine patch (an pain medicine) can make you much sleepier and slow your breathing more than either one alone. Both drugs calm the nervous system, so their effects can add up. Rarely, the combination might also raise the risk of , which can cause agitation, sweating, shaking, fast heartbeat, and fever. This link is mostly based on theory, but the sleepiness and breathing risk is taken seriously.
Don't stop either medicine on your own. Tell your pharmacist or doctor you use both. They can keep doses as low as possible, watch you closely, and may suggest keeping naloxone (an emergency overdose rescue medicine) at home.
Mechanism: (metaxalone plus a mu-opioid partial ) and possible additive . This is a interaction, not a -based one. Evidence is theoretical, though has been reported with metaxalone at therapeutic doses with serotonergic agents. Onset is unspecified. Buprenorphine is not a here, so the direction is of effect.
- Risks: profound , , coma, death; serotonin syndrome.
- Management: reserve for patients with inadequate alternatives; use lowest effective doses and shortest duration.
- Monitor: sedation, respiratory depression, urinary retention, severe constipation, and serotonergic signs.
- Strongly consider prescribing naloxone.
See the 3 references behind this explanation ↓
From the HelloPharmacist Pharmacy Team
AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .
How we build these pages · How we use AI · Our editorial policy
Why Buprenorphine Transdermal Patch and Metaxalone Interact
The likely mechanism
; additive
How to Manage the Buprenorphine Transdermal Patch and Metaxalone Interaction
Your care team will usually only combine these when other options aren't enough, and will aim for the lowest effective doses for the shortest time needed.
- Keep taking both exactly as prescribed unless your prescriber tells you otherwise.
- Expect closer monitoring for sleepiness, slowed breathing, urinary retention, and severe constipation.
- Ask whether you should have naloxone available, and make sure family knows how to use it.
- Report unusual drowsiness, confusion, slow breathing, agitation, sweating, tremor, or fever right away (seek emergency help for severe symptoms).
- Avoid alcohol and other sedating medicines unless your team approves.
Management is individual — confirm any change with your pharmacist or prescriber.
Questions for Your Pharmacist
- Does my dose of Buprenorphine Transdermal Patch or Metaxalone need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there another option that avoids this interaction?
Buprenorphine Transdermal Patch and Metaxalone: Common Questions
How serious is the Buprenorphine Transdermal Patch and Metaxalone interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How is the Buprenorphine Transdermal Patch and Metaxalone interaction managed?
Your care team will usually only combine these when other options aren't enough, and will aim for the lowest effective doses for the shortest time needed. Keep taking both exactly as prescribed unless your prescriber tells you otherwise. Expect closer monitoring for sleepiness, slowed breathing, urinary retention, and severe constipation. Ask whether you should have naloxone available, and make su… Management is individual — always follow your own care team's guidance.
Is there an alternative to taking Buprenorphine Transdermal Patch with Metaxalone?
The interaction record says a different medicine may be considered in place of one of these two.
Only your prescriber can decide whether a change fits you, so talk with them before changing either medicine.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Expected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.
Ask About the Buprenorphine Transdermal Patch and Metaxalone Interaction
Ask in your own words about taking Buprenorphine Transdermal Patch and Metaxalone together. The answer comes from this page’s interaction record and both drugs’ own information.
This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.
AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.
References (3)
- Product Information: SKELAXIN(R) oral tablets, metaxalone oral tablets. King Pharmaceuticals, Inc. (per FDA), Bristol, TN, 2018. DailyMed
- Product Information: Oxycodone HCl acetaminophen oral tablets, oxycodone HCl acetaminophen oral tablets. Mayne Pharma (per DailyMed), Greenville, NC, 2021.
- Product Information: CARISOPRODOL, ASPIRIN, CODEINE PHOSPHATE oral tablets, carisoprodol, aspirin, codeine phosphate oral tablets. Ingenus Pharmaceuticals LLC (per DailyMed), Orlando, FL, 2021. DailyMed
Other Serious Interactions of Buprenorphine Transdermal Patch and Metaxalone
Also serious with Metaxalone
Also serious with Buprenorphine Transdermal Patch
These Medications Also Interact With Supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
With Metaxalone
- Activated CharcoalMajor
- ProcaineMajor
- MagnesiumModerate
- Slippery ElmModerate
- GlucomannanModerate
- TragacanthModerate
- Coffee CharcoalModerate
- European MandrakeModerate
- + 12 more
Check everything you take with our drug–supplement interaction checker.
Still Have Questions About This Combination?
Every question gets a real answer from a licensed pharmacist — free, as soon as they can.
About This Library
Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →
What Each Rating Means
Severity Levels
- Contraindicated These should generally not be used together.
- Major Potentially serious — often needs a change or close monitoring. This interaction.
- Moderate Can be significant — usually manageable with monitoring.
- Minor Usually limited clinical impact.
Evidence Grades
- EstablishedWell documented — supported by controlled studies or strong clinical data.
- ProbableGood supporting evidence, though not definitively proven.
- SuspectedSome evidence suggests this interaction, but it is not well established.
- PossibleLimited or conflicting evidence; the interaction may occur.
- TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study. This interaction.
How Soon It Shows
- RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
- DelayedEffects tend to build up gradually over days to weeks.
- UnspecifiedThe timing of this interaction is not well characterized. This interaction.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.